Edition:
United States

Aprogen Pharmaceuticals Inc (003060.KS)

003060.KS on Korea Stock Exchange

3,650.00KRW
18 Aug 2017
Change (% chg)

₩-5.00 (-0.14%)
Prev Close
₩3,655.00
Open
₩3,640.00
Day's High
₩3,670.00
Day's Low
₩3,615.00
Volume
248,457
Avg. Vol
1,157,940
52-wk High
₩5,650.00
52-wk Low
₩2,990.00

Latest Key Developments (Source: Significant Developments)

Schnell Biopharmaceuticals to change co name to Aprogen Pharmaceuticals
Friday, 7 Apr 2017 05:26am EDT 

Schnell Biopharmaceuticals Inc <003060.KS> : Says it will change co name to Aprogen Pharmaceuticals Inc .Says effective date is April 12.  Full Article

Schnell Biopharmaceuticals to sell properties worth 7.4 bln won
Tuesday, 7 Mar 2017 05:21am EST 

Schnell Biopharmaceuticals Inc <003060.KS> : Says it will sell land and buildings located in Sangdaewon-dong, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea .Transaction amount is 7.4 billion won.  Full Article

Schnell Biopharmaceuticals to buy 9.5 pct stake in Locojoy International for 17 bln won
Thursday, 29 Dec 2016 04:21am EST 

Schnell Biopharmaceuticals Inc <003060.KS> : Says it will buy 4.5 million shares of Locojoy International Corporation, which is engaged in development and supply of mobile game related software . Says transaction amount is 17 billion won .Says it will hold 9.5 percent stake(4.5 million shares) in Locojoy International Corporation, after the transaction.  Full Article

Schnell Biopharmaceuticals to issue 12th convertible bonds worth 12 bln won
Tuesday, 31 May 2016 04:28am EDT 

Schnell Biopharmaceuticals,Inc. <003060.KS> : Says it will issue the 12th unregistered/unsecured private convertible bonds, raising 12 billion won in proceeds for operations . Maturity date of June 14, 2019, yield to maturity of 4.0 pct and annual coupon of 2.0 pct, lump-sum redemption of principal on maturity date for the bonds .A 100 pct conversion rate of bonds to common shares at 7,110 won per share, and a conversion period from June 14, 2017 to May 14, 2019.  Full Article

Schnell Biopharmaceuticals to issue 11th convertible bonds worth 11 bln won
Tuesday, 31 May 2016 04:26am EDT 

Schnell Biopharmaceuticals,Inc. <003060.KS> : Says it will issue the 11th unregistered/unsecured private convertible bonds, raising 11 billion won in proceeds for operations . Maturity date of June 7, 2019, yield to maturity of 4.0 pct and annual coupon of 2.0 pct, lump-sum redemption of principal on maturity date for the bonds .A 100 pct conversion rate of bonds to common shares at 7,110 won per share, and a conversion period from June 7, 2017 to May 7, 2019.  Full Article

Schnell Biopharmaceuticals,to issue 10th convertible bonds
Tuesday, 29 Mar 2016 04:40am EDT 

Schnell Biopharmaceuticals,Inc:To issue the 10th unregistered/unsecured private convertible bonds, raising 23,000 mln won in proceeds for operations.Maturity date of March 30, 2019, yield to maturity of 4.5 pct and annual coupon of 2.5 pct, lump-sum redemption of principal on maturity date for the bonds.A 100 pct conversion rate of bonds to common shares at 4,095 won per share, and a conversion period from March 30, 2017 to March 29, 2019.  Full Article

Schnell Biopharmaceuticals, announces change in shareholding structure
Wednesday, 23 Sep 2015 04:02am EDT 

Schnell Biopharmaceuticals,Inc:APROGEN,Inc's stake in the company was decreased to 7.74 pct (6,222,500 shares) down from 12.72 pct (20,445,000 shares).  Full Article

BRIEF-Schnell Biopharmaceuticals to change co name to Aprogen Pharmaceuticals

April 7 Schnell Biopharmaceuticals Inc : * Says it will change co name to Aprogen Pharmaceuticals Inc * Says effective date is April 12 Source text in Korean: https://goo.gl/xAhmys Further company coverage: (Beijing Headline News)

No consensus analysis data available.